12/01/2021
•2021Publication
Antimicrobial stewardship, rapid PCR and STI
Significant improvement to patient care and antimicrobial stewardship with appropriate use of antibiotics may be achieved through the use of rapid point-of-care PCR STI testing.
![ImpactBrief-BlogImage ImpactBrief-BlogImage](http://visbywpstaging.visbyon-site.net/wp-content/uploads/elementor/thumbs/ImpactBrief-BlogImage-qi71agt8myodw72vumnn6aaoy1gtftg4ijfsozdw0o.webp)
Challenge
Accurate same-day sexually transmitted infections (STI) diagnostic test results are generally unavailable, leading to syndromic management with high rates of over- and under-treatment, which contributes to antibiotic resistance.
Hypothesis: Might a rapid molecular diagnostic test help clinicians deliver the right treatment to women with STI during a single visit?
Action
Conduct a cross-sectional single-visit study to evaluate the Visby Medical Sexual Health Click Test with respect to:
- Ease of integration into clinical practice,
- Acceptance by patients and clinic personnel, and
- Potential to inform correct treatment decisions.
Result
- If integrated efficiently into the clinical workflow, the test would have minimal impact on staff time and visit duration for patients.
- Patients strongly agreed that self-collecting the vaginal swab was easy, and they were comfortable waiting up to 30-minutes to get results. Operators reported the device was easy to use. Clinicians valued the rapid results.
- Importantly, in 13 of 15 undertreated cases, the Visby Medical test correctly identified the causative pathogen. The test also correctly identified all 33 incidences of over-treatment. This suggests that clinical adoption of the Visby Medical test into primary care clinics could reduce over- and under-treatment of STIs, contributing to improved antimicrobial stewardship.
In addition, the following were observed:
- Reduced test turnaround time (TAT) from an average of 6 days for Standard of Care (SOC) down to ± 45 minutes for Visby Medical Sexual Health Click test
- Potential to reduce antibiotic overuse and associated effects on emerging antibiotic-resistant bacteria
- Potential to reduce delays in correctly identifying infected individuals by delivering test results in a single visit
- Improved physician and patient satisfaction
Conclusion
The biggest potential benefit of using a point of care molecular / polymerase chain reaction (PCR) test was the rapid turnaround time for delivery of the test results in a single visit. This would allow clinicians to treat patients based on the test results as opposed to empiric (presumptive) treatment, thereby reducing over- and under- treatment and reduced misuse of antibiotics.
Rate of patients over- or under-treated
Test TAT
See the full article here.
Read more articles & insights
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test
The Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) announced today that it will award biotechnology company Visby Medical of San Jose, California, up to $1.8 million
Visby Medical™ Receives FDA Clearance and CLIA Waiver for second Generation Sexual Health Test for Women
Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the FDA for its 2nd generation point of
Visby Medical Receives FDA Emergency Use Authorization for Respiratory Health Test for Use in CLIA Waived Settings
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of
Visby Medical Expands Series E Round to Over $135 Million
Visby Medical announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of